Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARPEGE: Gefitinib +/- WBRT in EGFR+ Lung Cancer with Brain Metastases
NCT01363557Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2012
- Primary completion
- Aug 2012
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in lung adenocarcinoma, brain metastasis (BM), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2012; status: terminated.
02
Drugs
03
Conditions
lung adenocarcinomabrain metastasis (BM)
Beyond the preview
Go deeper on NCT01363557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363557.